Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104704669 | 10470466 | 9 | F | 201409 | 20160719 | 20140923 | 20160728 | EXP | US-SA-2014SA106861 | AVENTIS | 64.00 | YR | A | F | Y | 0.00000 | 20160728 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104704669 | 10470466 | 1 | PS | AUBAGIO | TERIFLUNOMIDE | 1 | Oral | U | 5HX7ASA | 202992 | 14 | MG | QD | ||||||
| 104704669 | 10470466 | 2 | SS | AUBAGIO | TERIFLUNOMIDE | 1 | Oral | U | 5HX7ASA | 202992 | 14 | MG | QD | ||||||
| 104704669 | 10470466 | 3 | SS | AUBAGIO | TERIFLUNOMIDE | 1 | Oral | U | 5HX7ASA | 202992 | 14 | MG | QD | ||||||
| 104704669 | 10470466 | 4 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | Unknown | UNK | 0 | 500 | MG | BID | |||||||
| 104704669 | 10470466 | 5 | C | NITROFURANTOIN. | NITROFURANTOIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 104704669 | 10470466 | 1 | Multiple sclerosis |
| 104704669 | 10470466 | 2 | Multiple sclerosis |
| 104704669 | 10470466 | 3 | Multiple sclerosis |
| 104704669 | 10470466 | 4 | Urinary tract infection |
| 104704669 | 10470466 | 5 | Urinary tract infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 104704669 | 10470466 | HO |
| 104704669 | 10470466 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 104704669 | 10470466 | Activities of daily living impaired | |
| 104704669 | 10470466 | Asthenia | |
| 104704669 | 10470466 | Balance disorder | |
| 104704669 | 10470466 | Bladder discomfort | |
| 104704669 | 10470466 | Bladder disorder | |
| 104704669 | 10470466 | Blood pressure increased | |
| 104704669 | 10470466 | Cardiac failure congestive | |
| 104704669 | 10470466 | Cardiomyopathy | |
| 104704669 | 10470466 | Carotid artery stenosis | |
| 104704669 | 10470466 | Chest pain | |
| 104704669 | 10470466 | Diastolic dysfunction | |
| 104704669 | 10470466 | Discomfort | |
| 104704669 | 10470466 | Drug dose omission | |
| 104704669 | 10470466 | Dyspepsia | |
| 104704669 | 10470466 | Dyspnoea | |
| 104704669 | 10470466 | Ejection fraction decreased | |
| 104704669 | 10470466 | Fatigue | |
| 104704669 | 10470466 | Gait disturbance | |
| 104704669 | 10470466 | Haematocrit increased | |
| 104704669 | 10470466 | Haemoglobin increased | |
| 104704669 | 10470466 | Malaise | |
| 104704669 | 10470466 | Myocardial necrosis marker increased | |
| 104704669 | 10470466 | Oxygen saturation decreased | |
| 104704669 | 10470466 | Pain in extremity | |
| 104704669 | 10470466 | Pain in jaw | |
| 104704669 | 10470466 | Palpitations | |
| 104704669 | 10470466 | Restrictive pulmonary disease | |
| 104704669 | 10470466 | Urinary tract infection | |
| 104704669 | 10470466 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 104704669 | 10470466 | 1 | 20140722 | 20140910 | 0 | |
| 104704669 | 10470466 | 2 | 20140917 | 20150212 | 0 | |
| 104704669 | 10470466 | 3 | 20150424 | 0 |